Joel Greenblatt’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Joel Greenblatt's AXSM Position: Q3 2026 in Review
Joel Greenblatt increased its Axsome Therapeutics (AXSM) stake by 208% in Q3 2026, buying an estimated $443K and bringing the position to 3,018 shares worth $556K. The position accounts for ﹤0.01% of the portfolio, ranked #1566.
Joel Greenblatt first reported a position in AXSM in Q2 2019 and has held it in 4 quarters since. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Joel Greenblatt held 3,018 shares of Axsome Therapeutics worth $556K as of Q3 2026.
- Joel Greenblatt bought 2,038 Axsome Therapeutics shares in Q3 2026, an estimated $443K.
- Axsome Therapeutics made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1566 holding.
- Joel Greenblatt first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 4 quarters since.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.